English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5141]
News [14910]
Articles [105]
Editorials [3]
Conferences [247]
elearning [21]
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475...
Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston...
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014
Role of genomics in assessing risk, especially in ovarian cancer
Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014
The relationship between obesity and cancer, and other dietary factors
Dr Walter C. Willett - Harvard School of Public Health, Boston, USA
The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )
25 Apr 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
16 Apr 2014
I-SPY 2 trial shows promising development for some breast cancer patients using...
Dr John W. Park - University of California, San Francisco Hellen Diller Family...
I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )
16 Apr 2014
The global control and prevention of cervical cancer caused by HPV
Prof Thomas Broker - University of Alabama, Birmingham, USA
The global control and prevention of cervical cancer caused by HPV ( Prof Thomas Broker - University of Alabama, Birmingham, USA )
11 Apr 2014
Ganetespib in first-line treatment of women with metastatic HER2 positive or...
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
Regular physical activity reduces breast cancer risk irrespective of age
Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Regular physical activity reduces breast cancer risk irrespective of age ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
31 Mar 2014
Radiotherapy after mastectomy benefit for breast cancer that has spread to just...
Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )
31 Mar 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
Immuno-biological properties of human cancer stem cells
Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena...
Immuno-biological properties of human cancer stem cells ( Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy )
24 Mar 2014
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche...
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014
<1...387388389390391...429>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top